Curated News
By: NewsRamp Editorial Staff
April 08, 2026
BioStem Showcases Expanded Wound Care Portfolio at Premier SAWC Conference
TLDR
- BioStem Technologies gains a competitive edge by showcasing its expanded Neox product line at SAWC, offering clinicians differentiated options backed by clinical trials and real-world evidence.
- BioStem Technologies presents its perinatal tissue allograft products at SAWC, detailing processing technologies, clinical data, and portfolio expansion through symposiums, posters, and booth demonstrations.
- BioStem Technologies advances wound care by equipping clinicians with evidence-based regenerative medicine solutions, potentially improving patient outcomes and expanding access to advanced healing technologies.
- BioStem Technologies hosts a lunch symposium titled 'A New Season in Wound Care' at SAWC, featuring expert discussions on diabetic foot ulcer trials and clinical integration.
Impact - Why it Matters
This news matters because it highlights significant advancements in regenerative medicine that directly impact patient care and clinical practice. BioStem's expanded portfolio, particularly the Neox Product line, represents important progress in wound healing technologies that could benefit millions suffering from chronic wounds like diabetic foot ulcers. The company's presentation of clinical trial data and practical guidance at SAWC means healthcare providers gain access to evidence-based solutions that could improve healing times and reduce complications. For patients, this translates to potentially better outcomes, reduced hospital stays, and improved quality of life. The regenerative medicine field is rapidly evolving, and BioStem's commitment to research and education helps advance the entire industry toward more effective treatments.
Summary
BioStem Technologies, a leading regenerative medicine company specializing in perinatal tissue allograft products, is making a significant impact at the prestigious Symposium on Advanced Wound Care (SAWC) Spring 2026 meeting in Charlotte, NC. The company, led by Chairman and CEO Jason Matuszewski, is showcasing its expanded product portfolio, with particular emphasis on the recently introduced Neox Product line. This addition enhances BioStem's capabilities across multiple tissue formats, providing physicians with differentiated options tailored to specific clinical needs, handling preferences, and site-of-care requirements. The company's participation underscores its commitment to advancing wound care science and equipping clinicians with evidence-based tools to improve patient outcomes.
During the conference, BioStem is actively engaging with wound care professionals through multiple channels. The company has scheduled booth hours throughout the event and is hosting an Innovation Theater Lunch Symposium titled "A New Season in Wound Care: An Expanded Portfolio Grounded in Evidence." This session features prominent experts including Dr. Wendy Weston, PhD, CTBS, William Marston, MD, and Herbert Slade, MD, who will discuss key topics such as the science behind BioStem's innovative birth tissue products and recently published randomized controlled trial results on diabetic foot ulcers. Additionally, BioStem is presenting a new scientific poster (LR-020) in Exhibit Hall 1C, demonstrating the company's ongoing investment in clinical research and medical education.
BioStem Technologies' comprehensive portfolio includes quality brands like Neox®, Clarix®, VENDAJE®, and American Amnion™, all processed using proprietary technologies such as BioRetain®, CryoTek®, and SteriTek®. The company's quality management system has been accredited by the American Association of Tissue Banks and complies with current Good Tissue Practices and Good Manufacturing Processes. For those interested in following the company's developments, BioStem encourages professionals to sign up for their email distribution list HERE and connect through their social media channels on X and LinkedIn. The company's latest news and updates relating to $BSEM are available through their dedicated newsroom, and readers can Add PRISM MediaWire as their preferred news source on Google for continued coverage of innovative medical advancements.
Source Statement
This curated news summary relied on content disributed by PRISM Mediawire. Read the original source here, BioStem Showcases Expanded Wound Care Portfolio at Premier SAWC Conference
